Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Ingredient Epoetin Zeta (Recombinant Human Erythropoietin)

Name: Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Ingredient Epoetin Zeta (Recombinant Human Erythropoietin)
Start: 2023-03-25
End: 2025-05-31
Location: AOK PLUS - Die Gesundheitskasse fur Sachsen und Thuringen

AOK PLUS - Die Gesundheitskasse fur Sachsen und Thuringen Germany has Released a tender for Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Ingredient Epoetin Zeta (Recombinant Human Erythropoietin) in Pharmaceuticals. The tender was released on Mar 25, 2023.

Country - Germany

Summary - Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Ingredient Epoetin Zeta (Recombinant Human Erythropoietin)

Deadline - May 31, 2025

MT reference number - 63864251

Product classification - Pharmaceutical products

Organization Details:

Address - Germany

Contact details - 565656565

Tender notice no. - 76454545

MT Ref Id - 63864251

Document Type - Tender Notices

Notice Details and Documents:

Description - Invitation for Bids are invited for Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Ingredient Epoetin Zeta (Recombinant Human Erythropoietin). The Invita tion for Bids has been released by AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen and the deadline is 2025-05-31. The notice is for Pharmaceutical products.

Mt Ref Id - 63864251

Deadline - May 31, 2025

View more tenders for

Pharmaceuticals Tenders Pharmaceutical products Tenders Germany Tenders

Similar Tenders :

Most Searched